Nik Sharma

CEO & Co-Founder at BioCorteX

Presenter

BioCorteX is a Draper—Sofinnova backed tech bio with ambitions of transitioning the mainstream pharmaceutical industry to a new era where the interaction between bacteria and pharmaceuticals unlocks more effective therapeutics. While immune-oncology is the beachhead, BioCorteX will eventually tackle several therapeutic areas to dramatically improve the 4% success rate and reduce the $ 244 billion spent each year across drug development.